ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
Latest reported ACAD revenue for 2026-06-30 was $576.0M. Net income was $35.1M. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Use this ACAD page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ACAD quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ACAD SEC filings page. Lician reads the product cache first so this HTML stays unique to ACADIA Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full ACAD income, balance, and cash tables.